10 January 2019 - Heightened rhetoric from the administration and beyond make it clear that pharma’s complacency won’t be tolerated.

There’s a bit of cosmic justice in the fact that attending the pharmaceutical world’s biggest annual confab – the J.P. Morgan Chase & Co. Healthcare Conference in San Francisco – means, in many cases, being charged near-extortionate prices for hotel rooms and amenities. It’s not hard to draw a line to some of the industry’s own practices.

After ramming through New Year’s price increases, drug executives followed up this week with less-than-contrite messaging at the conference, signaling the industry’s reluctance to change in the face of constant criticism. The Trump administration wasn’t happy.

Read Bloomberg article